| |
Centre for Policy on Ageing | |
 | |
|
| Management of postmenopausal osteoporosis | | Author(s) | Marie A Chisholm, Anthony L Mulloy, Jasvir Singh |
| Journal title | Journal of Geriatric Drug Therapy, vol 12, no 4, 1999 |
| Pages | pp 3-20 |
| Keywords | Osteoporosis ; Menopause ; Drugs ; United States of America. |
| Annotation | Osteoporosis, a reduction in bone mass density, is the most common skeletal disorder in older people, and causes more than 1.5 million fractures a year costing the US healthcare system some $14 billion. Osteoporotic fractures cause pain, disability, and in some cases, death. Although osteoporosis is a preventable and treatable condition, many post-menopausal women with osteoporosis are unaware of their fragile skeletal condition until fracture occurs. Early diagnosis of osteoporosis is possible by measuring bone density, and by targeting those at greatest risk of developing osteoporotic fractures. Treatment with calcium, oestrogen, raloxifene, calcitonin, or alendronate stabilises bone density in older people and reduces the risk of fracture. This article reviews the current strategies for evaluation, diagnosis and management of osteoporosis. (RH). |
| Accession Number | CPA-000601401 A |
| Classmark | CLO: CC:BD: LLD: 7T |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|